Where do we stand in enzyme replacement therapy in Pompe's disease?

Neuromuscul Disord. 2010 Dec;20(12):773-4. doi: 10.1016/j.nmd.2010.09.011.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Enzyme Replacement Therapy*
  • Glucan 1,4-alpha-Glucosidase / therapeutic use*
  • Glycogen Storage Disease Type II / therapy*
  • Humans

Substances

  • Glucan 1,4-alpha-Glucosidase